Boston Scientific Stock - Analyst consensus stays positive as medtech peers diverge
Published on 06/19/2026 at 21:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:10 UTC. Details in the imprint.
Boston Scientific (US10117L1017) stock trades close to its recent range highs while analyst consensus on the medtech group remains broadly constructive. The shares continue to be rated Buy on average, according to several aggregated broker surveys.
All news and data on Boston Scientific stock
Key figures, corporate updates and peer comparisons help investors understand how Boston Scientific stock is positioned within the global medtech sector.
How Boston Scientific trades now
Boston Scientific shares most recently closed at around $45.30 on Nasdaq on 06/18/2026, with after-hours indications near $45.43, according to MarketBeat price data. MarketBeat lists the latest BSX quote and news flow.
Another trading snapshot shows BSX at roughly $45.28, implying a market capitalization of about $67.3 billion at a price/earnings multiple close to 19 based on trailing earnings. Arincen provides an overview of Boston Scientific valuation metrics.
Analyst stance and sector comparison
Across several data providers, Boston Scientific stock carries an overall Buy rating, with consensus highlighting steady growth in cardiology and minimally invasive therapies. TradingKey cites BSX with a Buy consensus rating and a positive long-term target spread.
Compared with large medtech peers such as Abbott, Medtronic and Johnson & Johnson's device arm, Boston Scientific sits in the mid-range on valuation, but with above-average growth expectations in structural heart and electrophysiology.
The company is also part of the Standard & Poor's 500 index, which means BSX often trades with broader US large-cap risk sentiment rather than only sector-specific news.
The product engine behind the group
Boston Scientific generates most of its revenue from minimally invasive medical devices used in cardiology, electrophysiology, endoscopy and urology. Flagship product platforms include drug-eluting coronary stents, transcatheter heart valves and implantable devices to treat cardiac rhythm disorders.
Where the stock trades today
The shares of Boston Scientific (US10117L1017) trade on Nasdaq at about $45.30 as of 06/18/2026, 16:00 Eastern Time.
Key facts on Boston Scientific stock
- Company: Boston Scientific Corp.
- ISIN: US10117L1017
- WKN: 879553
- Ticker: BSX
- Venue: Nasdaq
- Price (as of 06/18/2026, 16:00 ET): 45.30 USD
- Market cap: 67,300,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
